Point72 Asset Management’s NextCure NXTC Stock Holding History

Point72 Asset Management’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,982	Closed	-$1.28M	–	1043
2020 Q2	$1.28M	Buy	+4,982	New	+$1.9M	0.01%	652

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Point72 Asset Management's NXTC Position: Q3 2020 in Review

Point72 Asset Management sold out of NextCure (NXTC) in Q3 2020, closing a stake of 4,982 shares — an estimated $1.28M sold.

Point72 Asset Management first reported a position in NXTC in Q2 2020 and held it in 1 quarter. The position peaked at $1.28M in Q2 2020. 75 funds tracked by Wall St. Rank hold NXTC as of Q3 2020.

Point72 Asset Management reported no remaining NextCure position as of Q3 2020 after selling out during the quarter.
Point72 Asset Management sold 4,982 NextCure shares in Q3 2020, an estimated $1.28M.
Point72 Asset Management first reported a position in NextCure in Q2 2020 and held it in 1 quarter.
Point72 Asset Management's NextCure position peaked at $1.28M in Q2 2020.
75 funds tracked by Wall St. Rank held NextCure as of Q3 2020.

Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.